Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.

scientific article published on 27 January 2017

Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/ACR.23018
P698PubMed publication ID28129475

P50authorMary De VeraQ84061189
P2093author name stringEric C Sayre
John M Esdaile
J Antonio Aviña-Zubieta
Fergus To
Kateryna Vostretsova
P2860cites workA new method of classifying prognostic comorbidity in longitudinal studies: development and validationQ29547376
Estimation of failure probabilities in the presence of competing risks: new representations of old estimatorsQ33594562
The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseasesQ33885581
Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based studyQ33926524
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health studyQ34017775
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusQ34098573
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from SwedenQ34236174
Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from SwedenQ34307622
Selection bias in rheumatic disease researchQ34662693
Validity of myocardial infarction diagnoses in administrative databases: a systematic reviewQ35135179
Atherosclerosis in systemic lupus erythematosusQ35525108
Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review.Q35751558
Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.Q36773986
Purposeful selection of variables in logistic regressionQ37077675
Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohortQ37684625
The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic reviewQ38082909
Prevention and management of co-morbidities in SLE.Q38214067
The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based studyQ39121484
Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosusQ41608189
Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies.Q43861291
Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up studyQ43885994
Poor outcomes after acute myocardial infarction in systemic lupus erythematosusQ46308819
Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based studyQ48767991
Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus.Q51129973
P433issue6
P921main subjectsystemic lupus erythematosusQ1485
myocardial infarctionQ12152
P304page(s)849-856
P577publication date2017-05-09
P1433published inArthritis Care and ResearchQ15754720
P1476titleRisk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study
P478volume69

Reverse relations

cites work (P2860)
Q45871052Gender related issues in thrombosis and hemostasis
Q49946886Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein.
Q89603158Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Q89947833No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus
Q40123760Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis
Q90000657Risk factors for progression of carotid intima-media thickness in patients with systemic lupus erythematosus: protocol for an observational cohort study in China
Q90432999Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders
Q90175554Trends of venous thromboembolism risk before and after diagnosis of gout: a general population-based study
Q50092295Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999-2014).

Search more.